Search Results 531-540 of 16284 for VEO-IBD

1. Neurology - Clinical trials - Mayo Clinic

   The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

2. DiGeorge syndrome (22q11.2 deletion syndrome) - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

3. Pazopanib Hydrochloride in Treating Patients with Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma - Mayo Clinic

   Inflammatory bowel disease (e.g., ulcerative colitis, Crohn's disease) or other gastrointestinal conditions which increase the risk of perforation; History ...

4. Small bowel cancer - Doctors and departments - Mayo Clinic

   This type of cancer starts in the small intestine. Find out more about symptoms and treatments, including surgery, chemotherapy and targeted therapy.

5. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

   Prior history, evidence, or diagnosis of inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis); Any prior diagnosis of irritable bowel ...

6. Small bowel cancer - Doctors and departments - Mayo Clinic

   This type of cancer starts in the small intestine. Find out more about symptoms and treatments, including surgery, chemotherapy and targeted therapy.

7. Primary Biliary Cholangitis (PBC) Clinical Trials - Mayo Clinic Research

   Primary Biliary Cirrhosis (PBC) is a serious, life--threatening, bile acid related liver disease of unknown cause. Without treatment, it frequently progresses ...

8. Medical Research & Education - Mayo Clinic News Network

   Microbiome Role in Cancer, IBD, Obesity, and Infections. Mayo Clinic Staff. January 14, 2019. First · Previous ... 215 · 216 · 217 · 218 · 219 · 220 · 221 ...

9. A Study To Assess Change In Disease Activity And Adverse Events Of Oral Upadacitinib In Adult And Adolescent Participants With Moderate To Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy - Mayo Clinic

   Upadacitinib is an approved drug for ulcerative colitis, atopic dermatitis, rheumatoid arthritis, psoriatic arthritis, and axial spondylarthritis and is being ...

10. https://www.mayoclinic.org/patient_consumer_faq.xml